From www.http://blank.org/.com 31/01/15 This may just be a pipe dream...

From www.http://blank.org/.com

31/01/15

This may just be a pipe dream that goes up in smoke, but hear us out...

As you probably are aware, the recent Phytotech (ASXYL) float went silly. This will encourage more medical cannabis acquisitions and IPO's to take advantage of the hysterical sentiment, similar to the graphite craze that came before it.

So we looked at a crop of ASX shells to determine the most likely candidate for a medical cannabis reverse takeover.

We settled on VTX Holdings (ASX:VTX).

Incidentally, VTX recently changed its name from Vortex Pipes, which would be an apt name for a high-tech bong manufacturer!

We like many things about this shell, including the fact it's not really a shell at all - the original name Vortex Pipes came from its dig-free pipe repair technology, which is now involved in a deal to list in Canada.

VTX will retain a substantial ownership in the corporate vehicle that will house the technology, called ShieldLiner, which itself has large potential commercial upside.

But right now we are more interested in what new flagship business VTX plans to acquire...

Here are a few hints:

Matthew Walker and James Robinson of Cicero Corporate stumped up the $960,000 seed funding that put the Phytotech IPO in motion.

Matthew Walker has been buying large tranches of VTX shares on market, including over $100,000 worth at 1.3c just a few days ago. VTX is trading at 1.4c currently, just one tick above the price Mr. Walker paid last week.

His mate James Robinson happens to be a director at VTX... and Peter Wall, the lawyer that engineered the Phtytotech deal, is Partner at Steinepris Paganin, the law firm that VTX uses.

So given the VTX register and management, and the recent buying interest, we think we may be onto something.